Glenmark launches malaria treatment drug in UK

REUTERS - Drugmaker Glenmark Pharmaceuticals Ltd said on Thursday its European unit had launched a generic version of GlaxoSmithKline's Malarone malaria treatment medicine, its first generic product in Britain.

Glenmark launched the drug after the revocation of Glaxo's patent on Malarone by the High Court in Britain, the Indian company said in a statement, adding the medicine had sales of $28 million in the year ended September.

(Reporting by Sumeet Chatterjee in MUMBAI; editing by Jane Baird)